Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is characterized by degeneration of the macula, the area of the retina responsible for fine central vision.
This preliminary study in South Florida showed that HBOT is effective in reactivating the inactive cells at the margins of the atrophic lesions and possibly stimulating the remaining retinal cells to a higher level of function, which may also slow or prevent the cellular apoptosis that leads to a progression or to the development of focal retinal atrophic areas.
Patients who had visual loss secondary to AMD underwent HBO treatment and achieved improvements in their visual acuity and/or visual field in cases considered untreatable by presently accepted methods. There were no complications, and the visual benefits achieved appear to be maintained at follow-up visits.